Spot® Ex Launches in Europe

Spot® Ex Launches in Europe

We’re excited to share that Spot® Ex Endoscopic Tattoo has received CE Mark and is now available in Europe. We’re thrilled to bring this important tool in the fight against colorectal cancer to the EU.

“Our mission at GI Supply is to help more GI physicians do more advanced endoscopic procedures safely and efficiently, and Spot Ex is a great next step in meeting those needs,” said GI Supply CEO, Luke Johnson. “We’re happy to expand the availability of Spot Ex into Europe and provide clinicians with the next step in the fight against colon cancer.”

As the medical community strengthens its fight against colon cancer, every possible means of surveillance is needed. The new ESGE guidelines recommend tattooing all lesions that need to be followed-up at future colonoscopy or surgery1 and Spot Ex is the only endoscopic tattoo with a long-term clinical surveillance indication. These improved indications also allow for faster follow-up in ongoing care.

Medical practitioners in the EU have already witnessed the clinical benefits of endoscopic tattooing, including Professor Cesare Hassan, Head of Endoscopy Unit at Nuovo Regina Margherita Hospital in Rome, “Advances in screening and therapy are helping reduce colon cancer death rates across Europe. Polypectomy and EMR are now common skills for gastroenterologists, and allow patients to get cancer cured without the need for traditional surgery. The new ESGE guidelines formulated by the most worldwide recognized experts recommend long‐term follow‐up of patients who had these procedures to detect and treat recurrences in order to reduce the risk of interval cancer.”

You can learn more about Spot Ex in Europe here:

Spot® Ex in the EU

Spot Ex European Press Releases:

1 – Ferlitsch M, Moss A, Hassan C, et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): ESGE Clinical Guideline. 2017.